相关实验视频

Updated: Jan 13, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

RFC4驱动胰腺癌的进展:预后相关性和功能证据

Jae Woong Koh¹, Seon-Joo Park²

¹Department of Ophthalmology, College of Medicine, Chosun University, Gwangju, Republic of Korea.

Anticancer research

|October 28, 2025

概括

复制因子C子单元4 (RFC4) 在胰腺癌中过度表达,导致瘤进展. 针对RFC4可能为胰腺腺癌提供一种新的治疗策略.

科学领域:

分子生物学分子生物学
癌症研究癌症研究
基因组学就是基因组学.

背景情况:

复制因子C (RFC) 复合体对于DNA复制和修复至关重要.
RFC子单位与各种癌症有关,但它们在胰腺癌中的作用尚不清楚.
在胰腺腺癌中RFC4的具体参与需要调查.

研究的目的:

分析RFC4在胰腺腺癌中的表达和临床意义.
研究RFC4在胰腺癌细胞系中的功能作用.
评估RFC4作为潜在的预后生物标志物和治疗点.

主要方法:

使用GEPIA2.2.使用RFC4表达和生存相关性的生物信息分析.
功能测试包括MTT,殖民地形成,细胞周期分析和Transwell测试.
在MIA Paca-2和PANC-1胰腺癌细胞中使用siRNA进行RFC4敲击.

主要成果:

在胰腺腺癌中,RFC4显著过度表达.
过度表达RFC4与较差的整体存活率相关.
RFC4 knockdown 抑制细胞增殖,殖民地形成,迁移和入侵,诱导G1/S阶段停止.

结论:

RFC4与胰腺癌的进展密切相关.
RFC4可以作为胰腺癌的预后生物标志物.
RFC4代表了胰腺癌治疗的潜在治疗标.

关键词:

在RFC4中,RFC4是指RFC4.细胞循环中的细胞循环.细胞的增殖细胞的增殖.这是入侵的入侵.移民移民迁移迁移胰腺癌是一种癌症.

更多相关视频

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...